Unknown

Dataset Information

Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations.


ABSTRACT:

Background and aim

The ongoing global pandemic due to SARS-CoV-2 caused a medical emergency. Since December 2019, the COVID-19 disease is spread across the globe through physical contact and respiratory droplets. Coronavirus caused a severe effect on the human immune system where some of the non-structural proteins (nsp) are involved in virus-mediated immune response and pathogenesis. To suppress the viral RNA replication mechanism and immune-mediated responses, we aimed to identify limonoids and triterpenoids as antagonists by targeting helicases (nsp13), exonuclease (nsp14), and endoribonuclease (nsp15) of SARS-CoV-2 as therapeutic proteins.

Experimental procedure

In silico molecular docking and drug-likeness of a library of 369 phytochemicals from limonoids and tri

SUBMITTER: Vardhan S 

PROVIDER: S-EPMC8666293 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature